Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin and Colchicine in COVID-19
NCT05930002Completed
- Sponsor
- Ain Shams University
- Start
- Jul 2021
- Primary completion
- Sep 2022
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, open-label trial of CHILD-IVITAB and colchicine in coronavirus disease 2019 (COVID-19), sponsored by Ain Shams University. Started Jul 2021; status: completed.
02
Drugs
CHILD-IVITABcolchicine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05930002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05930002.